{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T06:30:21Z","timestamp":1721543421117},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Basic Grant Program","award":["50520"],"award-info":[{"award-number":["50520"]}]},{"name":"Research on Women Grant Program","award":["UO1-AI-35004","UO1-AI-31834","UO1-AI-34994","UO1-AI-34989","UO1-AI-34993","UO1-AI-42590"],"award-info":[{"award-number":["UO1-AI-35004","UO1-AI-31834","UO1-AI-34994","UO1-AI-34989","UO1-AI-34993","UO1-AI-42590"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["UO1-HD-32632"],"award-info":[{"award-number":["UO1-HD-32632"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","award":["UL1 RR024131"],"award-info":[{"award-number":["UL1 RR024131"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.cyto.2011.08.018","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T22:35:32Z","timestamp":1314830132000},"page":"325-331","source":"Crossref","is-referenced-by-count":9,"title":["Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women"],"prefix":"10.1016","volume":"56","author":[{"given":"Jos\u00e9","family":"Bord\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Plankey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Villacres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey L.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savitri","family":"Appana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Durkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Fernandez-Botran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2011.08.018_b0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-126-2-199701150-00005","article-title":"Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary complications of HIV infection study group","volume":"126","author":"Markowitz","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cyto.2011.08.018_b0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cyto.2011.08.018_b0015","unstructured":"UNAIDS. Frequently asked questions about tuberculosis and HIV, 2006. http:\/\/data.unaids.org\/pub\/FactSheet\/2006\/tb_hiv_qa.pdf."},{"key":"10.1016\/j.cyto.2011.08.018_b0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri1666","article-title":"Immune responses to tuberculosis in developing countries: implications for new vaccines","volume":"5","author":"Rook","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2011.08.018_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1086\/426827","article-title":"How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in south African gold miners","volume":"191","author":"Sonnenberg","year":"2005","journal-title":"J Infect Dis"},{"issue":"RR15","key":"10.1016\/j.cyto.2011.08.018_b0195","first-page":"1","article-title":"Treating opportunistic infections among HIV-infected adults and adolescents","volume":"53","author":"Benson","year":"2004","journal-title":"MMWR"},{"key":"10.1016\/j.cyto.2011.08.018_b0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","article-title":"Immunity to tuberculosis","volume":"22","author":"North","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CMR.15.2.294-309.2002","article-title":"Innate immunity to Mycobacterium tuberculosis","volume":"15","author":"Van Crevel","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cyto.2011.08.018_b0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","article-title":"IL-4 in tuberculosis: implications for vaccine design","volume":"25","author":"Rook","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-007-9084-0","article-title":"Host innate immune response to Mycobacterium tuberculosis","volume":"27","author":"Bhatt","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0060","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1164\/ajrccm.162.supplement_3.15tac1","article-title":"Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design","volume":"162","author":"Howie","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cyto.2011.08.018_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/003655401750065472","article-title":"High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels","volume":"33","author":"Seah","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cyto.2011.08.018_b0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-3083.1999.00492.x","article-title":"In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement","volume":"49","author":"Dlugovitzky","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1165\/ajrcmb.24.2.4274","article-title":"Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-\u03b1 or interleukin-12","volume":"24","author":"Marchant","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.cyto.2011.08.018_b0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/422532","article-title":"Increased IL-4 production by CD8 and \u03b3\u03b4 cells in health care workers is associated with the subsequent development of active tuberculosis","volume":"190","author":"Ordway","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2011.08.018_b0085","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4049\/jimmunol.156.2.435","article-title":"An alternative splice variant of IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation","volume":"156","author":"Atamas","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0090","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/01.aids.0000183520.52760.ef","article-title":"Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection","volume":"19","author":"Dheda","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.cyto.2011.08.018_b0095","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.4049\/jimmunol.172.11.6938","article-title":"VACSEL Study Group, Healthy individuals that control a latent infection with Mycobacterium tuberculosis express higher levels of Th1 cytokines and the IL-4 antagonist IL-4\u03b42","volume":"172","author":"Demissie","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":"The Women\u2019s Interagency HIV Study, WIHS Collaborative Study Group","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"10.1016\/j.cyto.2011.08.018_b0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":"The Women\u2019s Interagency HIV Study: an observational cohort brings clinical sciences to the bench","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0115","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.162.4.2441","article-title":"Expression of the IL-12 receptor \u03b21 and \u03b22 subunits in human tuberculosis","volume":"162","author":"Zhang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0120","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.280.5368.1432","article-title":"Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency","volume":"280","author":"Altare","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cyto.2011.08.018_b0125","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1183\/09031936.01.17510490","article-title":"Interleukin-12 as successful adjuvant in tuberculosis treatment","volume":"17","author":"Greinert","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cyto.2011.08.018_b0130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.179.4.1361","article-title":"Impaired interleukin 12 production in human immunodeficiency virus-infected patients","volume":"179","author":"Chehimi","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.08.018_b0135","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/blood.V94.3.1003.415a15_1003_1011","article-title":"The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals","volume":"94","author":"Marshall","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2011.08.018_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"2","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1073\/pnas.022649799","article-title":"Human macrophage activation programs induced by bacterial pathogens","volume":"99","author":"Nau","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2011.08.018_b0150","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1073\/pnas.2235593100","article-title":"Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system","volume":"100","author":"Stanley","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2011.08.018_b0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.181.2.537","article-title":"Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by peripheral blood mononuclear cells: priming for IL-12 and tumor-necrosis factor-\u03b1 production","volume":"181","author":"D\u2019Andrea","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2011.08.018_b0165","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.4049\/jimmunol.159.11.5705","article-title":"Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients","volume":"159","author":"Marshall","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2011.08.018_b0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","article-title":"IL-23 and IL-17 in tuberculosis","volume":"41","author":"Khader","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2011.08.018_b0175","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2011.08.018_b0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/gene.2010.51","article-title":"Human gene expression profiles of susceptibility and resistance in tuberculosis","volume":"12","author":"Maertzdorf","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.cyto.2011.08.018_b0185","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl. Tuberc."},{"key":"10.1016\/j.cyto.2011.08.018_b0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jim.2007.07.012","article-title":"Loss of T cell responses following long-term cryopreservation","volume":"326","author":"Owen","year":"2007","journal-title":"J Immunol Methods"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611006818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611006818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T03:06:40Z","timestamp":1686280000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466611006818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1043466611006818"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.08.018","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}